The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2

Medicine and Dentistry

• Antiproliferative Activity 100%
• Everolimus 100%
• Endometrial Cancer 100%
• Cancer Cell 20%
• In Vitro 20%
• down Regulation 20%
• Promoter Region 20%
• Drug 10%
• Chemotherapeutic Agent 10%
• Cell Viability 10%
• Overall Survival 10%
• Prognosis 10%
• Protein Expression 10%
• Inpatient 10%
• Programmed Cell Death 10%
• Clinical Study 10%
• Binding Site 10%
• Cancer Growth 10%
• Drug Action 10%
• Aberration 10%
• Antiapoptotic 10%
• Mammalian Target of Rapamycin 10%
• Mammalian Target of Rapamycin Inhibitor 10%
• Endometrium 10%
• Drug Combination 10%

Biochemistry, Genetics and Molecular Biology

• Insulin-Like Growth Factor-Binding Protein 100%
• Antiproliferative Activity 100%
• IGFBP2 100%
• Cancer Cell 20%
• down Regulation 20%
• Promoter Region 20%
• Growth 10%
• Apoptosis 10%
• Cell Viability 10%
• Mutation 10%
• Overall Survival 10%
• Protein Expression 10%
• Drug Mechanism 10%
• Binding Site 10%
• Endometrium 10%
• PI3K/AKT/mTOR Pathway 10%